Accord Logo

Intended for UK patients and members of the public

PIL- Bortezomib Accord 2.5 mg/ml solution for injection: Change history

  • 1. To update sections 4.6 and 5.3 of the SPC in with the

    reference product, VELCADE 1 mg/3.5 mg powder for solution

    for injection, EU procedure number:

    EMEA/H/C/000539/II/0102, MAH: JANSSEN CILAG

    INTERNATIONAL NV, Belgium.

     

    2. To update the ATC Code for Bortezomib Accord 3.5mg/1mg

    powder for solution for injection from “L01XX32” to

    “L01XG01” as published by WHO. Consequently, section 5.1

    of the SPC has been updated.

     

    Additionally, sections 2, 4.8, 5.1, 5.2 and 6.5 of the SPC and

    sections 2 and 4 of the leaflet have been updated with editorial

    changes in line with reference product.

    • Changes: (Updated: 27 Mar 2025)

      1. To update sections 4.6 and 5.3 of the SPC in with the

      reference product, VELCADE 1 mg/3.5 mg powder for solution

      for injection, EU procedure number:

      EMEA/H/C/000539/II/0102, MAH: JANSSEN CILAG

      INTERNATIONAL NV, Belgium.

       

      2. To update the ATC Code for Bortezomib Accord 3.5mg/1mg

      powder for solution for injection from “L01XX32” to

      “L01XG01” as published by WHO. Consequently, section 5.1

      of the SPC has been updated.

       

      Additionally, sections 2, 4.8, 5.1, 5.2 and 6.5 of the SPC and

      sections 2 and 4 of the leaflet have been updated with editorial

      changes in line with reference product.

    • Changes: (Updated: 20 Sep 2022)

      Initial upload

    View product information as a: